H. M. El-Beltagi

Statistics

Publications

Citations

H-Index

Active since

1993

Affiliations

H. M. El-Beltagi is an author at Erasmus University Rotterdam specializing in acute myeloid leukemia treatment, clinical pharmacology, and acute myeloid leukemia therapy.

Publications per year

1993–1993

Publications

Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia.

H. M. El-Beltagi, Andrew Martens, P. Lelieveld et al. · PubMed · 1993 · 50 citations

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy of acetyldinaline for treatment of minimal residual disease (MRD): preclinical studies in the BNML rat model for human acute myelocytic leukemia.

H. M. El-Beltagi, Anton C. Martens, Gamal M. Dahab et al. · PubMed · 1993 · 13 citations

Medicine, Oncology, Pharmacology +7

1–2 of 2